Press Releases June 30, 2026 04:30 PM

Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026

Resmed Announces Date for Fourth Quarter Fiscal 2026 Earnings Release and Webcast

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
RMD

Resmed will release its financial and operational results for the fourth quarter of fiscal 2026 on August 6, 2026, after the NYSE closes. A webcast will follow to discuss the results and forward-looking information.

Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026
RMD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings report scheduled for August 6, 2026, with a webcast for investors.
  • Resmed focuses on AI-powered digital health solutions and cloud-connected devices for home healthcare.
  • Company operates globally, serving 140 countries with innovative sleep health technologies.

SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, August 6, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

  • Location:         https://investor.resmed.com
  • Date:               Thursday, August 6, 2026
  • Time:               1:30 p.m. PT / 4:30 p.m. ET
  • International:   London, Thursday, August 6, 2026, 9:30 p.m. BST
                            Sydney, Friday, August 7, 2026, 6:30 a.m. AEST

Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from August 6, 2026, until August 20, 2026, at:

  • U.S.: +1 877.660.6853
  • International: +1 201.612.7415
  • Conference ID: 13761408

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

For investorsFor media+1 858.221.3304+1 [email protected]@Resmed.com


Risks

  • Potential uncertainties in financial performance not detailed in the announcement.
  • Market reaction depends on financial results and guidance to be revealed during the webcast.
  • Broader healthcare technology sector dynamics including regulatory and competitive pressures may impact future performance.

More from Press Releases

REE Automotive Announces Receipt of Nasdaq Delisting Notice Jul 3, 2026 Nayax Adds AI Layer to its MoMa Mobile App for Vending and Self-Service Operators Jul 3, 2026 CN Reports June Grain Movement Jul 3, 2026 CN to Report Second-Quarter 2026 Financial and Operating Results on July 24, 2026 Jul 3, 2026 FSI ANNOUNCES THE COMPANY HAS TRADED EQUITY IN THE FLORIDA LLC FOR EXCLUSIVE PRODUCT RIGHTS Jul 3, 2026